Home/ Stocks/ SGHT

Sight Sciences, Inc. Common Stock

SGHT XNAS

$7.47 +0.38 (+5.36%) ▲ 15-min delayed

Open

$7.24

High

$7.60

Low

$7.03

Volume

374.8K

Market Cap

$390.57M

About Sight Sciences, Inc. Common Stock

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 186 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$23.39M	$-4,446,000	$-0.08
Q1 2026	$19.70M	$-12,980,000	$-0.24
FY 2025	$77.36M	$-38,426,000	$-0.74
Q3 2025	$19.91M	$-8,169,000	$-0.16

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for SGHT yet. Check out our latest market news or earnings calendar.

Get SGHT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Sight Sciences, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.